# Pressure Ulcer Devices Market Forecast to Reach US$7.93 Billion by 2035 as Prevention Moves Beyond the Mattress | Report by DataM Intelligence

- Link: https://www.thailand-business-news.com/pr-news/pressure-ulcer-devices-market-forecast-to-reach-us7-93-billion-by-2035-as-prevention-moves-beyond-the-mattress-report-by-datam-intelligence
- Published: 2026-10-21T21:28:00+07:00
- Author: MarketersMEDIA Newswire

_DataM Intelligence’s report segments the market by product type, pressure-ulcer
stage, end user and region. It evaluates market size and share alongside competitive
positioning, country-level conditions and product developments._

Leander, Texas, United States, October 21, 2026 /MarketersMEDIA/ — The global [Pressure Ulcer Devices Market](https://www.datamintelligence.com/research-report/pressure-ulcer-devices-market)
is forecast to grow from **US$4.11 billion in 2025** to **US$7.93 billion by 2035**,
at a compound annual growth rate of **6.8% **between 2026 and 2035, according to
DataM Intelligence. The market includes pressure-relief mattresses and specialty
beds, cushions, positioning accessories, advanced wound dressings, negative-pressure
wound therapy systems used in pressure-ulcer care, and sensor-enabled monitoring
products. Connected monitoring is drawing attention, but it also faces a proof threshold:
purchasers need to know whether the information changes care decisions and improves
outcomes enough to justify added cost and training.

![](https://storage.googleapis.com/mmstudio-images/gallery/R3ukasqFCGcEzUIlHl9CCuLI6a92/
89206868-1792592915-1.jpg)

**Request Sample: [https://www.datamintelligence.com/download-sample/pressure-ulcer-devices-market](https://www.datamintelligence.com/download-sample/pressure-ulcer-devices-market)**

**Key Takeaways**

 * **2025 Market Size:** US$4.11 billion
 * **2035 Projected Market Size**: US$7.93 billion
 * **Forecast CAGR**, 2026–2035: 6.8%
 * **Largest Product Segment**: Pressure relief mattresses, 30.81% share in 2025
 * **Largest Region**: North America, 42.17% share in 2025
 * **Fastest-Growing Region**: Asia-Pacific, reported CAGR of 8.7%
 * **Fastest-Growing Product Segment**: Alternating pressure wheelchair cushions,
   reported 15.76% share in 2025

**United States**

More than 2.5 million people in the United States develop pressure ulcers each year,
according to the Agency for Healthcare Research and Quality. Hospitals also face
an economic incentive to reduce hospital-acquired conditions: the Centers for Medicare&
Medicaid Services reduces overall Medicare payments by 1% for applicable hospitals
in the worst-performing quartile under its Hospital-Acquired Condition Reduction
Program. The program covers a set of conditions and quality measures, so this penalty
should not be interpreted as a pressure-ulcer-specific payment reduction.

That environment supports demand for products that can be used consistently within
prevention protocols. The practical test is how support surfaces, dressings and 
repositioning practices work together across intensive care, surgery, transport,
post-acute care and home settings. For connected products, procurement teams are
likely to ask for evidence of clinical value, compatibility with existing workflows
and clarity on how patient data will be handled.

**Japan**

Japan’s 2025 population estimates counted 36.19 million people aged 65 or older,
or 29.4% of the population-the highest proportion recorded at that time by the Statistics
Bureau of Japan. Demand therefore spans hospitals, nursing homes and homecare, with
product selection shaped by patient mobility, caregiver workload and how easily 
a device fits the care environment.

Japan is also seeing activity across both established equipment makers and emerging
medical-AI developers. Domestic product launches and research programs point to 
interest in better pressure management and wound assessment. However, a product’s
clinical usefulness, regulatory status, service support and ease of operation remain
important adoption considerations. DataM Intelligence’s report does not publish 
Japan’s market revenue or share separately, so this release does not assign a country-
level market value.

**Recent Developments:**

 * **May 27, 2026 – FDA clearance for RENASYS EDGE:** The U.S. Food and Drug Administration
   found Smith+Nephew’s negative-pressure wound therapy pump substantially equivalent
   to a legally marketed device. The clearance adds a new system to the wound-management
   category; its use must follow the product’s cleared indications.
 * **June 1, 2026 – Smith+Nephew launches next-generation LEAF in the U.S.:** The
   patient-monitoring system uses a wearable sensor to track mobility and provide
   turn-status updates, linking pressure-injury prevention with care-team workflow.
 * **August 2026 – VA/DoD issues updated pressure-injury guidance:** The clinical
   practice guideline supports repositioning as part of prevention but identifies
   insufficient evidence for continuous bedside pressure mapping as a general recommendation.
   It highlights cost, staff training and implementation as factors that need consideration.
   The guidance raises the evidence bar for sensor-based products seeking broad 
   adoption.
 * **August 20, 2026 – Focus Systems advances pressure-ulcer AI development in Japan:**
   The company obtained a Class II medical-device manufacturing and marketing license.
   It said its pressure-ulcer AI work is progressing toward clinical performance
   testing following a development consultation with Japan’s Pharmaceuticals and
   Medical Devices Agency (PMDA). This is a development program, not a product approval.
 * **August 31, 2026 – CAPE lists its new Rasim product in Japan:** The pressure-
   care specialist’s product catalog identifies Rasim as a new product. The launch
   adds to a domestic portfolio that includes air mattresses, foam mattresses, positioning
   products and wheelchair cushions.
 * **September 24, 2026 – FDA posts a Baxter mattress recall:** The Class II recall
   covered specified PRO+ mattress surfaces because of an error in the product description
   on the UDI label. The notice concerns labeling; it should not be read as a finding
   of a pressure-redistribution performance defect.
 * **October 1, 2026 – Molten confirms the end of Rayos sales:** The Japanese company
   ended sales of its robotic mattress at the close of September and said it would
   generally hold repair parts through September 2031, subject to availability and
   product condition. The notice makes service continuity a consideration for facilities
   using the system.

**Purchase This Exclusive Report: [https://www.datamintelligence.com/buy-now-page?report=pressure-ulcer-devices-market](https://www.datamintelligence.com/buy-now-page?report=pressure-ulcer-devices-market)**

**Market Segmentation**

**Pressure-relief mattresses held the largest product share at 30.81% in 2025.**
The category covers a range of products, from foam and gel surfaces to powered alternating-
pressure and low-air-loss systems. Its broad use across hospitals, nursing homes
and homecare supports its leading position. However, product specifications differ
by patient acuity, mobility, cleaning protocols and the care setting.

**Alternating-pressure wheelchair cushions accounted for 15.76% of the market in
2025.** The segment addresses prolonged seated pressure and extends the market beyond
bed-based care. Portability, battery operation, setup and maintenance can influence
use in homes and outpatient settings. These products serve a distinct need and are
not a substitute for clinical assessment or other prevention measures.

**Injury stage shapes the mix of products used.** Stage I and II care places greater
emphasis on early intervention, pressure redistribution, moisture control, and protective
dressings. More advanced wounds may require specialty surfaces, dressings and, where
clinically appropriate, negative-pressure wound therapy. The report does not provide
stage-level revenue shares, so no percentages are assigned.

**Company Profiles**

**Stryker Corporation**

Stryker offers support surfaces for beds and stretchers, including IsoAir, Isolibrium,
IsoTour and ComfortGel. This portfolio lets the company address pressure-management
needs across different hospital environments, including critical care and patient
transport. Its positioning is tied to the broader acute-care equipment system: bed
compatibility, patient handling and clinical workflows can influence a facility’s
selection alongside surface performance.

**Baxter International (Hillrom)**

Baxter’s Hillrom portfolio includes pressure-management mattresses and hospital 
beds. The company describes AccuMax Quantum as a non-powered surface that redistributes
pressure as a patient moves or is repositioned; its VersaCare bed is designed to
support pressure-injury protocols and patient turning. The breadth of the portfolio
supports deployment across medical-surgical and intensive-care settings. Recent 
FDA labeling action also underlines the importance of accurate product identification
and traceability in equipment management.

**Smith+Nephew**

Smith+Nephew participates in prevention and wound management through foam dressings,
negative-pressure wound therapy and patient monitoring. Its ALLEVYN dressings are
positioned for wound management and to support pressure-injury prevention protocols,
while the next-generation LEAF system monitors patient mobility. RENASYS EDGE received
FDA 510(k) clearance in May 2026. Together, these offerings give the company exposure
to different steps in the care pathway, although each product’s use remains governed
by its indications and clinical protocols.

**Request a Customized Report According to Your Business Strategy: [https://www.datamintelligence.com/customize/pressure-ulcer-devices-market](https://www.datamintelligence.com/customize/pressure-ulcer-devices-market)**

Contact Info: 
Name: Sai KiranEmail: [Send Email](https://send.releasecontact.com/89206868)
Organization: DataM Intelligence 4Market Research LLPAddress: 2243 Rocoso TRL, Leander
TX 78641Phone: +1 877 441 4866Website: [https://www.datamintelligence.com/](https://www.datamintelligence.com/)

Release ID: 89206868

Should any errors, concerns, or inconsistencies arise from the content provided 
in this press release that require attention or if a press release needs to be taken
down, we kindly request that you immediately contact us at [error@releasecontact.com](https://www.thailand-business-news.com/pr-news/error@releasecontact.com)(
it is important to note that this email is the authorized channel for such matters,
sending multiple emails to multiple addresses does not necessarily help expedite
your request). Our efficient team will be at your disposal for timely assistance
within 8 hours – taking necessary measures to rectify identified issues or providing
guidance on the removal process. We prioritize delivering accurate and reliable 
information.

**Source** : [Pressure Ulcer Devices Market Forecast to Reach US$7.93 Billion by 2035 as Prevention Moves Beyond the Mattress | Report by DataM Intelligence](https://news.marketersmedia.com/pressure-ulcer-devices-market-forecast-to-reach-usdollar793-billion-by-2035-as-prevention-moves-beyond-the-mattress-or-report-by-datam-intelligence/89206868?rand=206000)

    ```wp-block-verse
    The information provided in this article was created by MarketersMEDIA Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Thailand Business News.
    ```
